Engitix appoints drug discovery and data science executives

Engitix Ltd, a UK biotechnology company with a portfolio of drug discovery programmes in fibrosis and solid tumours, has expanded its leadership team with the appointments of Matthew Edwards as senior vice president of discovery sciences and Emma Huang as vice president of data sciences. Both executives are joining Engitix from Johnson & Johnson. At Engitix, Dr Edwards will lead internal drug discovery scientific strategy focused on the company’s human extracellular matrix (ECM) platform. Dr Huang will lead the company’s data and analytics strategy supporting platform development, internal drug discovery pipeline and external partnerships.
Engitix announced the appointment on 27May 2024